Atlas Trials

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

Clinical trial NCT03801200 · UNKNOWN

Trial details

NCT number
NCT03801200
Sponsor
Hubei Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2020-09-10
Primary completion
2021-09-10
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.